These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947 [TBL] [Abstract][Full Text] [Related]
23. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
24. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842 [TBL] [Abstract][Full Text] [Related]
25. Analysis of PTEN/MMAC1 alteration in neuroblastoma. Moritake H; Horii Y; Kuroda H; Sugimoto T Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059 [TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913 [TBL] [Abstract][Full Text] [Related]
27. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines. Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646 [TBL] [Abstract][Full Text] [Related]
28. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490 [TBL] [Abstract][Full Text] [Related]
29. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767 [TBL] [Abstract][Full Text] [Related]
30. PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408 [TBL] [Abstract][Full Text] [Related]
31. Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071 [TBL] [Abstract][Full Text] [Related]
32. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766 [TBL] [Abstract][Full Text] [Related]
34. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743 [TBL] [Abstract][Full Text] [Related]
35. Intratumoral heterogeneity in microsatellite alterations in BRCA1 and PTEN regions in sporadic colorectal cancer. Garcia JM; Rodriguez R; Silva J; Muñoz C; Dominguez G; Silva JM; Carcereny E; Provencio M; España P; Bonilla F Ann Surg Oncol; 2003 Oct; 10(8):876-81. PubMed ID: 14527905 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859 [TBL] [Abstract][Full Text] [Related]
37. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Wang SI; Parsons R; Ittmann M Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551 [TBL] [Abstract][Full Text] [Related]
38. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients. Zainuddin N; Jaafar H; Isa MN; Abdullah JM Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579 [TBL] [Abstract][Full Text] [Related]
39. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986 [TBL] [Abstract][Full Text] [Related]
40. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]